Nephrocare Subsidiary Acquires Dialysis Center Assets in Philippines for PhP 151.6 Million
Nephrocare Health Care Services, Philippines Inc., an overseas step-down wholly-owned subsidiary of Nephrocare Health Services Limited, has entered into an Asset Transfer Agreement (ATA). The agreement, dated June 24, 2026, involves the acquisition of identified assets belonging to Curis Dialysis and Kidney Care Center.The transaction centers on the acquisition of a dialysis center located in Orion, Bataan 2102 - Region III (Central Luzon), Philippines. Nephrocare's subsidiary acquired these assets for a total consideration of PhP 151,600,000.
The agreement outlines the parties and the terms of the transaction. The Purchaser is Nephrocare Health Care Services, Philippines Inc., while the Seller is Curis Dialysis and Kidney Care Center.
Key details regarding the asset acquisition are summarized below:
| Particulars | Details |
|---|---|
| Purchaser | Nephrocare Health Care Services, Philippines Inc. (An overseas step-down wholly-owned subsidiary of the Company) |
| Seller | Curis Dialysis and Kidney Care Center |
| Transaction Purpose | Acquisition of dialysis center assets |
| Agreement Size | PhP 151,600,000 |
| Related Party Status | The Purchaser is a wholly-owned subsidiary of the Company. The Seller is not related to the company or its group. |
The Asset Transfer Agreement confirmed that there are no special rights granted under the terms of the agreement. Furthermore, both parties were confirmed not to be related party companies, and the transaction was executed at arm's length.
NEPHROPLUS Stock Price Movement
As of 3:11 PM, shares of Nephrocare Health Services Limited are slipping by 2.73% in live trading, currently priced at ₹661.20 as the market continues to trade. The equity experienced intraday movement across a significant range while registering a total volume of 116,153 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.